Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Atropos Therapeutics Logo
Atropos Therapeutics CB Rank
963832
Heat Score
47
Atropos Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer.
Founded
obfuscation
Private San Carlos, California, United States1-10 www.atroposthera.com/
Biotechnology
Pharmaceutical
Overview

Atropos Therapeutics
Heat Score
47

Growth Score
pts
in past quarter
Heat Score 47
-24 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Atropos Therapeutics

CB Rank
963832
Atropos Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer.
Founded
obfuscation
Private San Carlos, California, United States1-10 www.atroposthera.com/
Biotechnology
Pharmaceutical

Details

Operating Status Active
Company Type For Profit
Founders  Andrew Koff
About the Company
Atropos Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer.
Predictions & Insights

Growth Insight

See this Growth Insight
Atropos Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Senescence-Targeting Drugs
Drugs designed to target cellular senescence to treat aging-related diseases and cancer.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News

News and Press

News•May 23, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

597
-88.19%
 in past month

IT Spend

$656.2KThis year, Atropos Therapeutics is projected to spend $656.2K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Mozilla Logo
Mozilla
72
Firefox Logo
Firefox
72
Apple (AAPL) Logo
Apple (AAPL)
71

Active Website Tech Count

3Atropos Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is Atropos Therapeutics's headquarters? Atropos Therapeutics is located in San Carlos, California, United States.Who are Atropos Therapeutics's competitors? Alternatives and possible competitors to Atropos Therapeutics may include NewLimit, Life Biosciences, and  Oisin Biotechnologies.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(b4ae374 1)
|